Characterizing a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec from the Phase 3 Benegene-2 Study Who Returned to Factor IX Prophylaxis

Basit Öğe Kaydı
dc.contributor.authorFrenzel, Laurent
dc.contributor.authorKavakli, Kaan
dc.contributor.authorKlamroth, Robert
dc.contributor.authorChiou, Shyh-Shin
dc.contributor.authorShapiro, Amy D.
dc.contributor.authorSun, Pengling
dc.contributor.authorFuiman, Joanne
dc.date.accessioned2024-08-31T07:50:45Z
dc.date.available2024-08-31T07:50:45Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description65th Annual Meeting of the American-Society-of-Hematology (ASH) -- DEC 09-12, 2023 -- San Diego, CAen_US
dc.description.abstract[Abstarct Not Available]en_US
dc.description.sponsorshipAmer Soc Hematolen_US
dc.identifier.doi10.1182/blood-2023-181223
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.urihttps://doi.org/10.1182/blood-2023-181223
dc.identifier.urihttps://hdl.handle.net/11454/105356
dc.identifier.volume142en_US
dc.identifier.wosWOS:001159306708229en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240831_Uen_US
dc.titleCharacterizing a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec from the Phase 3 Benegene-2 Study Who Returned to Factor IX Prophylaxisen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu